Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2021

View Archived Issues

CCR6 antagonist PF-07054894 for autoimmune disorders

International researchers discover first nonhormonal treatment target for endometriosis

Increased atrial proarrhythmic activity seen in murine model of OSA

Janssen Biotech divulges DHODH inhibitors

Mindset Pharma patents 5-HT2A receptor agonists

TroBio Therapeutics presents new compounds for cancer

U.K. researchers synthesize new antifungals

New benzimidazole derivative as a selective RORgamma inverse agonist for prostate cancer treatment

Scientists discover and characterize a selective hCYP11B2 PET tracer for primary hyperaldosteronism

New heart failure animal model also captures arrhythmia susceptibility

Low-dose targeted radionuclide therapy using [90Y]NM-600 promotes response to ICIs

New class of Mcl-1 inhibitors developed at Janssen for treating myeloma

Investigators identify new gene mutations behind hereditary optic neuropathy

Preclinical data highlight CAN-04 mode of action in potentiating efficacy of docetaxel

Genexine divulges new anti-PD-L1 fusion proteins

Satellos determines high-resolution crystal structure of target for Duchenne muscular dystrophy

Sonnet selects SON-1410 as development candidate for melanoma and renal cancers

Type of RPE65 variant is associated with age at onset of inherited retinal dystrophies

New genes identified to cause nonsyndromic cleft palate

Polymorphisms in the IRAK2 gene are associated with RA susceptibility

hsa-miR-34b-5p as novel diagnostic marker in male infertility

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...